Aijun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aijun Liu has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Dongfeng Chen
Department of Anatomy, The Research Center of Basic Integrative Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China
8 shared publications Xianxi Zhou
Department of Anatomy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China
7 shared publicationsChunmei Ma
School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China
5 shared publicationsHaoxiang Ye
Department of Anatomy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China
4 shared publicationsJiahui Cao
4 shared publicationsBaolin Ye
School of Basic Medical Sciences Guangzhou University of Chinese Medicine Guangzhou China
3 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
Ethyl Stearate Improves Mitochondrial Function in Parkinson’s Disease via SIRT2/PGC‑1α/NRF1 and UPRmt
Ethnopharmacological relevance: Plastrum Testudinis (Gui Jia, turtle shell) has been documented in Shennong Bencao Jing and Compendium of Materia Medicafor treating "Chan Zheng" (tremor and convulsion), a clinical phenotype corresponding to extrapyramidal symptoms in Parkinson's disease (PD). Modern phytochemical studies have identified ethyl stearate as a bioactive constituent of Plastrum Testudinis extracts. Aim of the study : This study aimed to investigate the neuroprotective effects and underlying mechanisms of ethyl stearate in 6-OHDA‑lesioned rats and differentiated PC12 cells, focusing on mitochondrial quality control and the SIRT2/PGC‑1α/NRF1 signaling axis. Materials and methods: Male Sprague‑Dawley rats received stereotaxic injection of 6‑OHDA into the substantia nigra and striatum. Motor function was evaluated by apomorphine‑induced rotation and pole‑climbing tests. Mitochondrial membrane potential, reactive oxygen species (ROS), and protein expression were measured by JC‑1 staining, DCFH‑DA assay, qRT‑PCR, Western blotting, and immunofluorescence. Molecular docking was performed to predict the interaction between ethyl stearate and SIRT2. Results: Ethyl stearate significantly improved motor deficits, restored tyrosine hydroxylase (TH) expression, and reduced α‑synuclein aggregation in PD models. It restored mitochondrial membrane potential, decreased ROS overproduction, and downregulated HSP60, indicating alleviated mitochondrial proteotoxic stress and effective activation of the mitochondrial unfolded protein response (UPRmt). Molecular docking demonstrated stable binding of ethyl stearate to the SIRT2 active pocket (−7.3 kcal/mol). Furthermore, ethyl stearate significantly attenuated the aberrant upregulation of PGC‑1α and NRF1, restoring them to near-normal levels. Conclusions: Ethyl stearate improves mitochondrial function in PD via SIRT2‑mediated regulation of PGC‑1α/NRF1 signaling and UPRmt activation. This study provides pharmacological evidence supporting the traditional use of Plastrum Testudinis as a treatment for tremor‑related disorders and identifies ethyl stearate as a promising lead compound for PD intervention targeting mitochondrial proteostasis.
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEthyl Stearate Improves Mitochondrial Function in Parkinson’s Disease via SIRT2/PGC‑1α/NRF1 and UPRmt
Ethnopharmacological relevance: Plastrum Testudinis (Gui Jia, turtle shell) has been documented in Shennong Bencao Jing and Compendium of Materia Medicafor treating "Chan Zheng" (tremor and convulsion), a clinical phenotype corresponding to extrapyramidal symptoms in Parkinson's disease (PD). Modern phytochemical studies have identified ethyl stearate as a bioactive constituent of Plastrum Testudinis extracts. Aim of the study : This study aimed to investigate the neuroprotective effects and underlying mechanisms of ethyl stearate in 6-OHDA‑lesioned rats and differentiated PC12 cells, focusing on mitochondrial quality control and the SIRT2/PGC‑1α/NRF1 signaling axis. Materials and methods: Male Sprague‑Dawley rats received stereotaxic injection of 6‑OHDA into the substantia nigra and striatum. Motor function was evaluated by apomorphine‑induced rotation and pole‑climbing tests. Mitochondrial membrane potential, reactive oxygen species (ROS), and protein expression were measured by JC‑1 staining, DCFH‑DA assay, qRT‑PCR, Western blotting, and immunofluorescence. Molecular docking was performed to predict the interaction between ethyl stearate and SIRT2. Results: Ethyl stearate significantly improved motor deficits, restored tyrosine hydroxylase (TH) expression, and reduced α‑synuclein aggregation in PD models. It restored mitochondrial membrane potential, decreased ROS overproduction, and downregulated HSP60, indicating alleviated mitochondrial proteotoxic stress and effective activation of the mitochondrial unfolded protein response (UPRmt). Molecular docking demonstrated stable binding of ethyl stearate to the SIRT2 active pocket (−7.3 kcal/mol). Furthermore, ethyl stearate significantly attenuated the aberrant upregulation of PGC‑1α and NRF1, restoring them to near-normal levels. Conclusions: Ethyl stearate improves mitochondrial function in PD via SIRT2‑mediated regulation of PGC‑1α/NRF1 signaling and UPRmt activation. This study provides pharmacological evidence supporting the traditional use of Plastrum Testudinis as a treatment for tremor‑related disorders and identifies ethyl stearate as a promising lead compound for PD intervention targeting mitochondrial proteostasis.
- 31 August 2026
- Published by Wiley in Journal of Polymer Science
pH ‐Responsive Loureirin A‐Modified Sodium Alginate‐Based Hydrogel for Accelerating Skin Wound Healing
Wound repair demands multifunctional dressings that simultaneously provide antibacterial protection, promote angiogenesis, and enable responsive drug release. Loureirin A (LA), the principal active component of Dragon's Blood, exhibits antibacterial and pro‐healing effects; however, its poor water solubility and low local bioavailability limit therapeutic efficacy. Copper ions (Cu 2+ ) possess antibacterial activity but carry burst‐release toxicity risks. This study proposed a natural product–inorganic ion synergistic controlled‐release strategy: mesoporous polydopamine nanoparticles (MPDA) were employed to achieve high LA loading, and Cu 2+ was ionically crosslinked with sodium alginate (SA) to construct a pH‐responsive MCLS hydrogel, with the network stabilized by hydrogen and disulfide bonds. This system enabled coordinated LA and Cu 2+ release under weakly acidic wound conditions. The MCLS hydrogel showed a porous microstructure, appropriate mechanical properties, and pH‐dependent release. In vitro, it exhibited antibacterial activity against Staphylococcus aureus and Escherichia coli and demonstrated cytocompatibility. In a rat full‐thickness skin defect model, the hydrogel accelerated wound closure, promoted fibroblast migration and tube formation, and upregulated CD31 and VEGF‐A expression, indicating enhanced angiogenesis. This study provides an experimental basis for functional wound dressings based on the synergistic combination of natural active ingredients and inorganic ions.
- 31 August 2026
- Published by Wiley in Journal of Polymer Science
pH ‐Responsive Loureirin A‐Modified Sodium Alginate‐Based Hydrogel for Accelerating Skin Wound Healing
Wound repair demands multifunctional dressings that simultaneously provide antibacterial protection, promote angiogenesis, and enable responsive drug release. Loureirin A (LA), the principal active component of Dragon's Blood, exhibits antibacterial and pro‐healing effects; however, its poor water solubility and low local bioavailability limit therapeutic efficacy. Copper ions (Cu 2+ ) possess antibacterial activity but carry burst‐release toxicity risks. This study proposed a natural product–inorganic ion synergistic controlled‐release strategy: mesoporous polydopamine nanoparticles (MPDA) were employed to achieve high LA loading, and Cu 2+ was ionically crosslinked with sodium alginate (SA) to construct a pH‐responsive MCLS hydrogel, with the network stabilized by hydrogen and disulfide bonds. This system enabled coordinated LA and Cu 2+ release under weakly acidic wound conditions. The MCLS hydrogel showed a porous microstructure, appropriate mechanical properties, and pH‐dependent release. In vitro, it exhibited antibacterial activity against Staphylococcus aureus and Escherichia coli and demonstrated cytocompatibility. In a rat full‐thickness skin defect model, the hydrogel accelerated wound closure, promoted fibroblast migration and tube formation, and upregulated CD31 and VEGF‐A expression, indicating enhanced angiogenesis. This study provides an experimental basis for functional wound dressings based on the synergistic combination of natural active ingredients and inorganic ions.
- Open Access
- 14 August 2025
- Published by Elsevier in Materials Today Bio
- Vol. 34, 102196
Light up the mitochondria: Smart tungstate-oligosaccharide nanoplatform orchestrates mitochondrial transfer from M2 macrophages to restore endothelial function for adaptive diabetic wound regeneration
- 14 August 2025
- Published by Elsevier in Materials Today Bio
- Vol. 34, 102196
Open AccessLight up the mitochondria: Smart tungstate-oligosaccharide nanoplatform orchestrates mitochondrial transfer from M2 macrophages to restore endothelial function for adaptive diabetic wound regeneration
- 15 May 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 158, 114847
L-borneol regulates rno-miR-127/ PODXL2 to promote hair follicle stem cells to repair skin wounds
- 15 May 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 158, 114847
L-borneol regulates rno-miR-127/ PODXL2 to promote hair follicle stem cells to repair skin wounds
- Open Access
- 24 November 2023
- Published by SAGE Publications in CARTILAGE
- Vol. 16 (3) , 333-344
Novel-miR-81 Promotes the Chondrocytes Differentiation of Bone Marrow Mesenchymal Stem Cells Through Inhibiting Rac2 Expression
Objective: MicroRNAs (miRNAs) play a key role in the differentiation of bone marrow–derived mesenchymal stem cells (BMSCs) into chondrocytes. Our previous study found that novel-miR-81 can relieve osteoarthritis, but its role in chondrogenic differentiation of BMSCs remains unclear. The purpose of this study was to explore the role of novel-miR-81 in chondrogenic differentiation of BMSCs. Methods: We used a model in which transforming growth factor (TGF)-β3-induced BMSCs differentiation into chondrocytes. We detected the expression Sox9, Collagen Ⅱ, Aggrecan, novel-miR-81, and Rac2 by real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Western blot was performed to detect the expression of Sox9, Collagen Ⅱ, and Rac2. Dual-luciferase reporter gene assay confirmed that the association between novel-miR-81 and Rac2. In addition, the ectopic chondrocyte differentiation of BMSCs was performed subcutaneously in nude mice. The effect of novel-miR-81 and Rac2 on ectopic chondrogenic differentiation of BMSCs was determined by immunohistochemical staining. Results: Novel-miR-81 upregulated in chondrogenic differentiation of BMSCs. Rac2 was a key target of novel-miR-81. Mimic novel-miR-81 and siRac2 upregulated the expression of Sox9, Collagen Ⅱ, and Aggrecan. Conclusion: Novel-miR-81 promotes the chondrocytes differentiation of BMSCs by inhibiting the expression of target gene Rac2, which provides potential targets for BMSCs transplantation to repair cartilage defects.
- 24 November 2023
- Published by SAGE Publications in CARTILAGE
- Vol. 16 (3) , 333-344
Open AccessNovel-miR-81 Promotes the Chondrocytes Differentiation of Bone Marrow Mesenchymal Stem Cells Through Inhibiting Rac2 Expression
Objective: MicroRNAs (miRNAs) play a key role in the differentiation of bone marrow–derived mesenchymal stem cells (BMSCs) into chondrocytes. Our previous study found that novel-miR-81 can relieve osteoarthritis, but its role in chondrogenic differentiation of BMSCs remains unclear. The purpose of this study was to explore the role of novel-miR-81 in chondrogenic differentiation of BMSCs. Methods: We used a model in which transforming growth factor (TGF)-β3-induced BMSCs differentiation into chondrocytes. We detected the expression Sox9, Collagen Ⅱ, Aggrecan, novel-miR-81, and Rac2 by real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Western blot was performed to detect the expression of Sox9, Collagen Ⅱ, and Rac2. Dual-luciferase reporter gene assay confirmed that the association between novel-miR-81 and Rac2. In addition, the ectopic chondrocyte differentiation of BMSCs was performed subcutaneously in nude mice. The effect of novel-miR-81 and Rac2 on ectopic chondrogenic differentiation of BMSCs was determined by immunohistochemical staining. Results: Novel-miR-81 upregulated in chondrogenic differentiation of BMSCs. Rac2 was a key target of novel-miR-81. Mimic novel-miR-81 and siRac2 upregulated the expression of Sox9, Collagen Ⅱ, and Aggrecan. Conclusion: Novel-miR-81 promotes the chondrocytes differentiation of BMSCs by inhibiting the expression of target gene Rac2, which provides potential targets for BMSCs transplantation to repair cartilage defects.
- Open Access
- 21 April 2023
- Published by SAGE Publications in CARTILAGE
- Vol. 15 (2) , 175-183
IL16 Regulates Osteoarthritis Progression as a Target Gene of Novel-miR-81
Objective: Functional polymorphisms of interleukin 16 (IL16) have been reported to be closely related to the risk of osteoarthritis (OA). However, how IL16 affects OA remains unclear. In this study, the role of IL16 in OA and the possible mechanisms were examined. Methods: We established a meniscal/ligament injury (MLI) post-traumatic OA model in Sprague Dawley rats and an IL1β-induced ADTC5 cells OA model. We detected the expression of IL16, novel-miR-81, MMP3, and MMP13 by quantitative real-time polymerase chain reaction. Western blot was performed to detect the expression of IL16, MMP3, and MMP13. The association between IL16 and novel-miR-81 was confirmed by luciferase reporter assay. Hematoxylin and eosin staining, Safranin O and Fast Green staining, and immunohistochemical staining were performed to clarify the effect of intra-articular injection of novel-miR-81 agomir in rats OA model. Results: IL16 was upregulated in OA model. Knockdown of IL16 and overexpression of novel-miR-81 downregulated the expression of MMP3 and MMP13. Importantly, IL16 was a key target of novel-miR-81. Intra-articular injection of novel-miR-81 agomir could attenuate OA progression in rats OA model. Conclusion: Novel-miR-81 targeted IL16 to relieve OA, suggesting that novel-miR-81and IL16 may be new therapeutic targets for OA.
- 21 April 2023
- Published by SAGE Publications in CARTILAGE
- Vol. 15 (2) , 175-183
Open AccessIL16 Regulates Osteoarthritis Progression as a Target Gene of Novel-miR-81
Objective: Functional polymorphisms of interleukin 16 (IL16) have been reported to be closely related to the risk of osteoarthritis (OA). However, how IL16 affects OA remains unclear. In this study, the role of IL16 in OA and the possible mechanisms were examined. Methods: We established a meniscal/ligament injury (MLI) post-traumatic OA model in Sprague Dawley rats and an IL1β-induced ADTC5 cells OA model. We detected the expression of IL16, novel-miR-81, MMP3, and MMP13 by quantitative real-time polymerase chain reaction. Western blot was performed to detect the expression of IL16, MMP3, and MMP13. The association between IL16 and novel-miR-81 was confirmed by luciferase reporter assay. Hematoxylin and eosin staining, Safranin O and Fast Green staining, and immunohistochemical staining were performed to clarify the effect of intra-articular injection of novel-miR-81 agomir in rats OA model. Results: IL16 was upregulated in OA model. Knockdown of IL16 and overexpression of novel-miR-81 downregulated the expression of MMP3 and MMP13. Importantly, IL16 was a key target of novel-miR-81. Intra-articular injection of novel-miR-81 agomir could attenuate OA progression in rats OA model. Conclusion: Novel-miR-81 targeted IL16 to relieve OA, suggesting that novel-miR-81and IL16 may be new therapeutic targets for OA.
- 23 January 2023
- Published by Wiley in The Anatomical Record
- Vol. 306 (8) , 2185-2198
rno‐miR‐90 promotes chondrogenic differentiation of bone marrow mesenchymal stem cells by targeting SPARC‐related modular calcium binding 2
Bone marrow mesenchymal stem cells (BMSCs) have the ability to differentiate into chondrocytes. In the differentiation of BMSCs into chondrocytes, micro‐RNAs (miRNAs) play an important role. rno‐miR‐90 is a new miRNA discovered by our research team, and its role in chondrogenic differentiation of BMSCs is unknown. This study aimed to investigate whether rno‐miR‐90 could promote chondrogenic differentiation of BMSCs by regulating secreted protein acidic and rich in cysteine‐related modular calcium binding 2 (Smoc2). First, BMSCs chondroblast differentiation was successfully induced in vitro by classical induction method of transforming growth factor (TGF)‐β3. On this basis, we transfected rno‐miR‐90 mimic and inhibitor, and confirmed that rno‐miR‐90 mimic could promote the differentiation of BMSCs into chondrocytes by real‐time reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR) and western blotting. In addition, we demonstrated that Smoc2 was a target gene of rno‐miR‐90 by dual‐luciferase reporter assay, and confirmed that rno‐miR‐90 mimic could inhibit the expression of Smoc2 by RT‐qPCR and western blotting. In order to further prove the targeting relationship between rno‐miR‐90 and Smoc2, we constructed three interfering fragments of Smoc2, and proved that silencing Smoc2 could promote the differentiation of BMSCs into chondrocytes at the transcriptional and protein levels. Finally, we constructed a carrier scaffold for ectopic chondrogenic differentiation in vivo, and confirmed that rno‐miR‐90 mimic and siSmoc2 could promote chondrogenic differentiation of BMSCs by Alcian blue staining and immunohistochemistry. In summary, our results suggested that rno‐miR‐90 could promote chondrogenic differentiation of BMSCs by down‐regulating the expression of Smoc2. rno‐miR‐90 mimic and Smoc2 may be therapeutic targets of osteoarthritis.
- 23 January 2023
- Published by Wiley in The Anatomical Record
- Vol. 306 (8) , 2185-2198
rno‐miR‐90 promotes chondrogenic differentiation of bone marrow mesenchymal stem cells by targeting SPARC‐related modular calcium binding 2
Bone marrow mesenchymal stem cells (BMSCs) have the ability to differentiate into chondrocytes. In the differentiation of BMSCs into chondrocytes, micro‐RNAs (miRNAs) play an important role. rno‐miR‐90 is a new miRNA discovered by our research team, and its role in chondrogenic differentiation of BMSCs is unknown. This study aimed to investigate whether rno‐miR‐90 could promote chondrogenic differentiation of BMSCs by regulating secreted protein acidic and rich in cysteine‐related modular calcium binding 2 (Smoc2). First, BMSCs chondroblast differentiation was successfully induced in vitro by classical induction method of transforming growth factor (TGF)‐β3. On this basis, we transfected rno‐miR‐90 mimic and inhibitor, and confirmed that rno‐miR‐90 mimic could promote the differentiation of BMSCs into chondrocytes by real‐time reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR) and western blotting. In addition, we demonstrated that Smoc2 was a target gene of rno‐miR‐90 by dual‐luciferase reporter assay, and confirmed that rno‐miR‐90 mimic could inhibit the expression of Smoc2 by RT‐qPCR and western blotting. In order to further prove the targeting relationship between rno‐miR‐90 and Smoc2, we constructed three interfering fragments of Smoc2, and proved that silencing Smoc2 could promote the differentiation of BMSCs into chondrocytes at the transcriptional and protein levels. Finally, we constructed a carrier scaffold for ectopic chondrogenic differentiation in vivo, and confirmed that rno‐miR‐90 mimic and siSmoc2 could promote chondrogenic differentiation of BMSCs by Alcian blue staining and immunohistochemistry. In summary, our results suggested that rno‐miR‐90 could promote chondrogenic differentiation of BMSCs by down‐regulating the expression of Smoc2. rno‐miR‐90 mimic and Smoc2 may be therapeutic targets of osteoarthritis.
- Open Access
- 22 November 2022
- Published by Springer Nature in Research Square
Bioinformatics analysis of ferroptosis-related genes in the pathogenesis of diabetic ulcers
Background: Diabetic ulcers are a major complication of diabetes which causing lower extremity amputation. Nonetheless, the progression in the development of diabetic ulcers therapeutics is slow. Ferroptosis plays a key role in the pathogenesis of chronic wound in diabetic ulcers. The mechanism needs to be further clarified. Methods: Ferroptosis-related differentially expressed genes (FRDEGs) in diabetic ulcers were screened from the dataset GSE92724 and FerrDb online database based in silico. Then, functional enrichment analysis and protein-protein interaction (PPI) network were implemented to recognize the potential biological pathways and mechanisms. MCODE tool was used to cluster and predict hub genes. The miRNAs corresponding to hub genes were predicted by miRWalk 2.0. Receiver operating characteristic (ROC) was applied to verify the diagnostic value of five hub genes in the dataset GSE132187 and GSE134431. The immune infiltration between diabetic ulcers samples and normal samples were analyzed by using CIBERSORTx. Results: 26 FRDEGs and 5 hub genes (EGFR, SLC2A1, CD44, CA9, and PTGS2) in diabetic ulcers were identified. GO and KEGG analysis revealed that hub genes were significantly enriched in response to oxidative stress, basolateral plasma membrane, and HIF-1 signaling pathway. ROC results suggested that hub genes have a high diagnostic accuracy for diabetic ulcers. In immune cell infiltration, T follicular helper cells and monocytes were significantly lower in diabetic ulcers. Conclusion: This research firstly demonstrated that five hub genes may be potential therapeutic targets and possible diagnostic biomarkers in the pathogenesis of diabetic ulcers.
- 22 November 2022
- Published by Springer Nature in Research Square
Open AccessBioinformatics analysis of ferroptosis-related genes in the pathogenesis of diabetic ulcers
Background: Diabetic ulcers are a major complication of diabetes which causing lower extremity amputation. Nonetheless, the progression in the development of diabetic ulcers therapeutics is slow. Ferroptosis plays a key role in the pathogenesis of chronic wound in diabetic ulcers. The mechanism needs to be further clarified. Methods: Ferroptosis-related differentially expressed genes (FRDEGs) in diabetic ulcers were screened from the dataset GSE92724 and FerrDb online database based in silico. Then, functional enrichment analysis and protein-protein interaction (PPI) network were implemented to recognize the potential biological pathways and mechanisms. MCODE tool was used to cluster and predict hub genes. The miRNAs corresponding to hub genes were predicted by miRWalk 2.0. Receiver operating characteristic (ROC) was applied to verify the diagnostic value of five hub genes in the dataset GSE132187 and GSE134431. The immune infiltration between diabetic ulcers samples and normal samples were analyzed by using CIBERSORTx. Results: 26 FRDEGs and 5 hub genes (EGFR, SLC2A1, CD44, CA9, and PTGS2) in diabetic ulcers were identified. GO and KEGG analysis revealed that hub genes were significantly enriched in response to oxidative stress, basolateral plasma membrane, and HIF-1 signaling pathway. ROC results suggested that hub genes have a high diagnostic accuracy for diabetic ulcers. In immune cell infiltration, T follicular helper cells and monocytes were significantly lower in diabetic ulcers. Conclusion: This research firstly demonstrated that five hub genes may be potential therapeutic targets and possible diagnostic biomarkers in the pathogenesis of diabetic ulcers.
- Open Access
- 1 May 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (10) , 540
Electroacupuncture of the Baihui and Shenting acupoints for vascular dementia in rats through the miR-81/IL-16/PSD-95 pathway
Original Article Electroacupuncture of the Baihui and Shenting acupoints for vascular dementia in rats through the miR-81/IL-16/PSD-95 pathway Chunmei Ma, Ying Zhou, Wei Yi, Xianxi Zhou, Wenping Guo, Xiaowu Xu, Jing Luo, Ziwei Luo, Aijun Liu, Dongfeng Chen
- 1 May 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (10) , 540
Open AccessElectroacupuncture of the Baihui and Shenting acupoints for vascular dementia in rats through the miR-81/IL-16/PSD-95 pathway
Original Article Electroacupuncture of the Baihui and Shenting acupoints for vascular dementia in rats through the miR-81/IL-16/PSD-95 pathway Chunmei Ma, Ying Zhou, Wei Yi, Xianxi Zhou, Wenping Guo, Xiaowu Xu, Jing Luo, Ziwei Luo, Aijun Liu, Dongfeng Chen